| Source HCPCS Code |
|
Target NDC Code |
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0505-13
SELARSDI 45 MG/0.5 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0505-32
SELARSDI 45 MG/0.5 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0607-32
SELARSDI 90 MG/ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0708-13
SELARSDI 130 MG/26 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
26 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0709-32
USTEKINUMAB-AEKN 45 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9998
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
|
⇄
|
51759-0710-32
USTEKINUMAB-AEKN 90 MG/ML SYR
|
| Detail Information |
| Relationship Start Date |
07/01/2025 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0505-13
Selarsdi
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0505-32
Selarsdi
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0607-32
Selarsdi
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0708-13
Selarsdi
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0709-32
Ustekinumab-AEKN
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q9998
Inj ustekinumab-aekn, 1 mg
|
⇄
|
51759-0710-32
Ustekinumab-AEKN
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|